Manufacturing facility
BAMF Health, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 109 Michigan Street NW, Suite 110, Grand Rapids, Michigan (MI) 49503, United States (USA)
- Operations here
- positron emission tomography drug production
- FDA identifiers
- FEI 3021097485 · DUNS 118390069
Drugs this plant is listed as making
4 distinct drugs across 4 products name this site in their FDA label.
- Fludeoxyglucose F-18BAMF Health Inc.
- Flutemetamol F-18GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare)
- Piflufolastat F-18Progenics Pharmaceuticals, Inc.
- Sodium Fluoride F-18BAMF Health Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.